Reimbursement Briefs: Express Scripts Formulary; EHR Incentives; ACA Exchanges
Express Scripts estimates savings from “not covered” drug list, GAO reports statistics on electronic health record adoption incentive payments, and CMS offers status report on exchange plan applications.
You may also be interested in...
Pharmaceutical companies are beginning to leverage big data to become more integrated into health care delivery, looking to care coordination and other “services adjacent to medicines,” IBM’s John Piccone reports.
Former senior advisor to President Trump warns that failure to reform drug pricing practices has seriously handicapped prospects for reimbursing cell and gene therapy under existing US payer programs.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’